IFKF

Dear Colleagues,

We hereby invite you to join us for the International Federation of Kidney Foundations  Foundation (IFKF F) 2nd  IFKF-WKA Consensus Conference on “Hepatitis C Infection and Global Kidney Health”, on Friday December 22, 2017, from 8 AM to 5 PM (08:00-17:00) in Conrad Cairo Hilton, Cairo, Egypt, hosted by the Egyptian Kidney Foundation (sponsored by the IFKF F and an unrestricted grant from Merck)

The 2017 IFKF F Annual General Meeting will follow at 18:00 to 20:00 same day, 22-Dec-2017, for IFKF Members only. If you cannot travel to Cairo, Skype conferencing will be available to remotely join the AGM.

Prof Gamal Saadi (Egypt), Prof. Michel Jadoul (Belgium) and Prof. Kam Kalantar-Zadeh (USA) invite you to participate as conference observant and/or contribute as faculty, kindly see below outlines of the program.  There will be 10-12 presentations by the invited HCV-in-CKD international experts. Each presentation should be 10-12 min at most, followed by 8-10 min discussion (up to 20 min total time per each session).  The consensus paper is expected to be published in American Journal of Nephrology, that is affiliated with the IFKF F, and the invited faculty will serve as coauthors of the paper.

Hepatitis C Infection and Global Kidney Health, an IFKF-WKA Consensus Conference

Day 1 (Thursday 21-Dec):  Dinner: 19:30-22:00 Day 2:  (Friday 22-Dec): 08:00 to 17:00, followed by IFKF F Annual General Meeting for members

Chairs:
Prof. Gamal Saadi, Egypt (IFKF F President) Prof. Kamyar Kalantar-Zadeh, USA (IFKF F President elect)
Prof. Michel Jadoul, Belgium

 Day 2 (Friday 2017-12-22)

08:00: Introduction (10 min)
08:10:  HCV global epidemiology (20 min)
08:30: HCV in persons with CKD (20 min)
08:50: HCV in Egypt and African (20 min)
09:10: HCV in Middle East and Israel (20 min)
09:30:  HCV in dialysis patients and mortality (20 min)

09:50-10:10 Coffee Break

10:10:  HCV in transplant patients Part 1 (20 min)
10:30:  HCV in NDD-CKD patients (20 min)
10:50: HCV and kidney transplant Part 2: Transition to transplant while HCV+ (20 min) 11:10:  HCV and glomerulonephritis (20 min)
11:30: Preventing HCV (20 min)
11:50:  Wrapping up morning sessions (10 min)

 12:00-13:00 Lunch Break
 
13:00: Treatment of HCV in NDD-CKD (20 min)
13:20: Treatment of HCV in Kidney Transplant Recipients (20 min)
13:40: Treatment of HCV in Dialysis Patients (20 min)
14:00: Success in Global Eradication of HCV (20 min)
14:20:  HCV and CKD in Europe & Americas (20 min)
14:40: HCV and CKD in Russia, India, China and Asian-Pacific regions (20 min)

15:00 Consensus paper writing discussions and break-out group (1 hr)
16:00 Group presentations (each 10-15 min, total 1 hr)
17:00 Adjourn

17:00-20:00 Break

18:00-20:00:  IFKF F 2017 Annual General Meeting for IFKF F Members,

Further information to follow.

20:00: Dinner and Social Event

 

Additional information